Literature DB >> 10668694

Discontinuation of antiepileptic drugs after successful epilepsy surgery.

Y Schiller1, G D Cascino, E L So, W R Marsh.   

Abstract

OBJECTIVE: To evaluate the frequency and risk factors for seizure recurrence subsequent to antiepileptic drug (AED) withdrawal in patients who underwent surgical treatment for intractable partial epilepsy and were rendered seizure-free.
METHODS: The outcome of discontinuation of AED medication was studied retrospectively in 210 consecutive patients who were rendered seizure-free after epilepsy surgery performed between 1989 and 1993.
RESULTS: Medical therapy was reduced in 96 patients and discontinued in 84 patients. The seizure recurrence rate after complete AED withdrawal was 14% and 36% at 2 and 5 years. In contrast, only 3% and 7% of the 30 patients who did not alter AED treatment after surgery had recurrent seizures in the same time intervals. After AED discontinuation, seizures tended to recur more often in patients with normal preoperative MRI studies compared with those with focal pathology. However, this difference did not reach significance. Intraoperative electrocorticography, extent of surgical resection, postoperative EEG, and seizure-free duration after surgery were not predictive of seizure outcome after AED withdrawal.
CONCLUSIONS: AED withdrawal was associated with seizure recurrence in a significant portion of patients rendered seizure-free by epilepsy surgery. Patients with a normal preoperative MRI study showed a tendency for higher seizure recurrence, whereas the duration of seizure-free postoperative AED treatment interval did not significantly influence the seizure recurrence rate. These results will prove useful in counseling patients about discontinuing AED treatment after successful epilepsy surgery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10668694     DOI: 10.1212/wnl.54.2.346

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Postsurgical treatment of epilepsy.

Authors:  Anne T Berg
Journal:  Epilepsy Curr       Date:  2004 Jul-Aug       Impact factor: 7.500

2.  Stopping antiepileptic drugs after epilepsy surgery: a survey of U.S. epilepsy center neurologists.

Authors:  Anne T Berg; John T Langfitt; Susan S Spencer; Barbara G Vickrey
Journal:  Epilepsy Behav       Date:  2007-01-23       Impact factor: 2.937

3.  Medication management after epilepsy surgery: opinions versus facts.

Authors:  Lara Jehi
Journal:  Epilepsy Curr       Date:  2013-07       Impact factor: 7.500

4.  Long-term seizure and psychosocial outcomes of epilepsy surgery.

Authors:  José F Téllez-Zenteno; Samuel Wiebe
Journal:  Curr Treat Options Neurol       Date:  2008-07       Impact factor: 3.598

5.  Does early postoperative drug regimen impact seizure control in patients undergoing temporal lobe resections?

Authors:  Barbara Schmeiser; Bernhard J Steinhoff; Andreas Schulze-Bonhage
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

Review 6.  Treatment of epileptic seizures in brain tumors: a critical review.

Authors:  R Bauer; M Ortler; M Seiz-Rosenhagen; R Maier; J V Anton; I Unterberger
Journal:  Neurosurg Rev       Date:  2014-04-24       Impact factor: 3.042

7.  Antiepileptic medications after extratemporal epilepsy surgery: when do we stop?

Authors:  Mohamad Koubeissi
Journal:  Epilepsy Curr       Date:  2013-01       Impact factor: 7.500

8.  Does epilepsy surgery convert medical intractable temporal lobe epilepsy to a medically treatable seizure disorder?

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2004 May-Jun       Impact factor: 7.500

Review 9.  Epilepsy surgery: chance for a cure.

Authors:  L Uber-Zak; D Blum
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

10.  Truly "rational" polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects.

Authors:  Erik K St Louis
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.